Drug intelligence / Profile preview

porcine skin acellular dermal matrix

Development stage
Unknown
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Surgical, Implantable, Topical
01

Overview

Porcine skin acellular dermal matrix is a biologically derived scaffold created by removing all cellular components from porcine (pig) skin while preserving the extracellular matrix structure and composition. The resulting product consists mainly of collagen fibers and basement membrane components such as fibronectin, elastin, laminin, glycosaminoglycans, and hyaluronic acid. This decellularized material acts as a scaffold for host cell infiltration and neovascularization when implanted in humans. It is designed to minimize immune rejection by eliminating antigenic cellular elements. The primary mechanism of action is to provide a biocompatible framework that supports tissue regeneration by promoting fibroblast migration, angiogenesis (new blood vessel formation), epithelialization, and ordered collagen fiber arrangement at the wound site. Porcine ADM serves as a temporary biological covering for wounds—especially deep burns or chronic ulcers—reducing exudate loss and infection risk while maintaining moisture balance conducive to healing. Clinical applications include treatment of extensive burns after excision or debridement; management of diabetic foot ulcers; coverage for traumatic wounds with significant tissue loss; reinforcement in hernia repair; adjunctive use in breast reconstruction surgery; abdominal wall reconstruction; tendon repair (e.g., Achilles tendon); craniofacial surgery; oral/maxillofacial procedures; gynecological repairs; orthopedic surgeries involving soft tissue defects. Porcine ADM has been shown to integrate into host tissues with minimal inflammatory response compared to synthetic meshes or allografts[1][2][3][4]. Complications may include hematoma, seroma formation, necrosis or infection at the graft site[1]. Its high cost can limit widespread use compared to synthetic alternatives[1].

Other names
porcine acellular dermal matrixxenogenic acellular dermal matrixXADMPADM

Beyond the preview

Go deeper on porcine skin acellular dermal matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on porcine skin acellular dermal matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call